To test, in this study, a subcutaneous B16F10 tumor model was established, and IFNγ, the effector cytokine of CD4+ Th1 cells, was in vivo neutralized post cryo-thermal therapy with a monoclonal antibody (mAb). This evidence concerns the gene IFNG and neoplasm.